{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-068710","form_type":"8-K","ticker":"PRPL","cik":"0001643953","company_name":"Purple Innovation, Inc.","filed_at":"2025-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.548086+00:00","generated_at":"2026-05-17T23:43:32.844017+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Purple Innovation Q2 net loss $17.3M; revenue down 12.6% to $105.1M; reaffirms FY2025 guidance","bullets":["Q2 revenue $105.1M, down 12.6% YoY; gross margin 35.9%, down 480 bps due to tariffs and ramp-up costs.","Net loss of $17.3M vs breakeven last year; adjusted EBITDA improved to $(2.4)M from $(4.1)M.","Reaffirmed FY2025 revenue guidance $465-485M and adjusted EBITDA flat to +$10M.","Cash increased to $34.2M at June 30, 2025 from $29.0M at Dec 31, 2024.","CEO cites strong Rejuvenate 2.0 demand and Mattress Firm rollout on track; Q3 revenue-to-date up mid-single digits."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-068710","json":"https://secwatch.observer/filing/0001213900-25-068710.json","markdown":"https://secwatch.observer/filing/0001213900-25-068710.md","text":"https://secwatch.observer/filing/0001213900-25-068710.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1643953/000121390025068710/0001213900-25-068710-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1643953/000121390025068710/ea0250535-8k_purple.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T23:43:32.844017+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}